Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

254 works between 1998 and 2025

141 - 160 of 254 works

2014

Conference Publication

Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis

Hennig, Stefanie, Teo, Beverly, Stiller, Franziska and Staatz, Christine (2014). Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis. PAGANZ 2014: 16th Annual Population Approach Group in Australia and New Zealand Meeting, Dunedin, New Zealand, 29-31 January, 2014. Auckland Central, Auckland, NZ: Population Approach Group of Australia and New Zealand (PAGANZ ).

Comparing dosage adjustment methods for once daily tobramycin in children with cystic fibrosis

2014

Conference Publication

A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom

Staatz, C. E., Paviour, S. and Hennig, S. (2014). A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom. Population Approach Group in Europe conference, Alicante, Spain, June 2014.

A survey of intravenous tobramycin monitoring and dosage adjustment practice in cystic fibrosis patients in Australia and the United Kingdom

2014

Conference Publication

Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure

Bergmann, TB, Isbel, NM, Barraclough, KA, Campbell, SB, McWhinney, BC and Staatz, CE (2014). Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, Janurary.

Cyclosporine and tacrolimus patients have similar dose adjusted prednisolone exposure

2014

Conference Publication

Bcl-Xl and McL1 Expression in Non Melanoma Skin Cancers in Renal Transplant Recipients

Burke, Michael, Morais, Christudas, Soyer, Peter, Sinnya, Sudipta, Winterford, Clay, Oliver, Kimberley, Lambie, Duncan, Staatz, Christine, Carroll, Robert, Campbell, Scott and Isbel, Nicole (2014). Bcl-Xl and McL1 Expression in Non Melanoma Skin Cancers in Renal Transplant Recipients. 51st Congress of the European Renal Association(ERA)/European Dialysis and Transplant Association (EDTA), Amsterdam Netherlands, 31 May- 03 June 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ndt/gfu161

Bcl-Xl and McL1 Expression in Non Melanoma Skin Cancers in Renal Transplant Recipients

2014

Journal Article

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

Størset, Elisabet, Holford, Nick, Hennig, Stefanie, Bergmann, Troels K., Bremer, Stein, Bergan, Sara, Åsberg, Anders, Midtvedt, Karsten and Staatz, Christine E. (2014). Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling. British Journal of Clinical Pharmacology, 78 (3), 509-523. doi: 10.1111/bcp.12361

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

2014

Conference Publication

Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation

Størset, E., Holford, N., Hennig, S., Bergmann, T. K., Bergan, S., Bremer, S., Åsberg, A., Midtvedt, K. and Staatz, C. E. (2014). Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation. Population Approach Group in Europe Conference, Alicante, Spain, June 2014.

Evaluation of dosing strategies to achieve targeted tacrolimus exposure after adult kidney transplantation

2014

Book Chapter

Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation

Barraclough, K. A., Staatz, C. E. and Isbel, N. M. (2014). Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation. The Complex Evolution of Kidney Transplantation: Pre-transplant Donor and Recipient Assessment, Transplant Surgery, Immunosuppression, High Risk Transplants and Management of Post Transplant Complications. (pp. 185-261) edited by Wai Hon Lim. New York, NY, USA: Nova Science Publisher.

Pharmacokinetic, pharmacogenetic and pharmacodynamic monitoring of tacrolimus, mycophenolate and oral corticosteroids in adult kidney transplantation

2014

Conference Publication

Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe

Staatz, C. E., Gardiner, K. M. and Tett, S. E. (2014). Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe. Joint meeting of ASCEPT and Molecular Pharmacology of G protein-coupled receptors (MGPPCR), Melbourne, Australia, 7-11th December 2014.

Comparing utilisation of mycophenolate, tacrolimus, cyclosporin, sirolimus and everolimus in Australia and Northern Europe

2013

Journal Article

Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis

Buendia, Jefferson A., Bramuglia, Guillermo and Staatz, Christine E. (2013). Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. Therapeutic Drug Monitoring, 36 (4), 442-447. doi: 10.1097/FTD.0000000000000032

Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis

2013

Journal Article

PharmGKB summary: cyclosporine and tacrolimus pathways

Barbarino, Julia M., Staatz, Christine E., Venkataramanan, Raman, Klein, Teri E. and Altman, Russ B. (2013). PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenetics and Genomics, 23 (10), 563-585. doi: 10.1097/FPC.0b013e328364db84

PharmGKB summary: cyclosporine and tacrolimus pathways

2013

Journal Article

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease

Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease

2013

Journal Article

A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients

Barraclough, Katherine A., Staatz, Christine E., Johnson, David W., Gillis, David, Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B. and Isbel, Nicole M. (2013). A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients. Therapeutic Drug Monitoring, 35 (2), 240-245. doi: 10.1097/FTD.0b013e31828286dd

A differential impact of mycophenolic acid, prednisolone, and tacrolimus exposure on scd30 levels in adult kidney transplant recipients

2013

Journal Article

Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis

Hennig, Stefanie, Standing, Joseph F., Staatz, Christine E. and Thomson, Alison H. (2013). Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clinical Pharmacokinetics, 52 (4), 289-301. doi: 10.1007/s40262-013-0036-y

Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis

2013

Conference Publication

Identification of continuous covariate relationships

Størset, Elisabet, Staatz, Christine, Hennig, Stefanie, Bergmann, Troels K. and Holford, Nick (2013). Identification of continuous covariate relationships. 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, 13-15 February 2013.

Identification of continuous covariate relationships

2013

Conference Publication

Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis

Buendia, J. A., Bramuglia, G. and Staatz, C. E. (2013). Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis. 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Salt Lake City Ut, 22-26 September 2013. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/FTD.0b013e3182a8ef2b

Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis

2013

Conference Publication

A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.

Bergmann, T. K., Hennig, S., Barraclough, K. A., Isbel, N. M. and Staatz, C. E. (2013). A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, January 2013.

A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.

2013

Journal Article

Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.

Bergman, Troels K., Hennig, Stefanie, Barraclough, Katherine A., Isbe,l Nicole M. and Staatz, Christine E. (2013). Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.. Therapeutic Drug Monitoring, 36 (1), 62-70. doi: 10.1097/FTD.0b013e31829f1ab8

Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.

2013

Conference Publication

Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom

Paviour, Sophie, Hennig, Stefanie and Staatz, Christine (2013). Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom. 39th SHPA National Conference, Cairns, Australia, 19-22 September 2013.

Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the United Kingdom

2013

Conference Publication

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

Staatz, C. E., Bergmann, T. K., Barraclough, K. A., Isbel, N. M. and Hennig, S. (2013). Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Population Approach Group in Europe conference, Glasgow, Scotland, June 2013.

Population pharmacokinetics of tacrolimus in adult kidney transplant recipients

2013

Conference Publication

A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients

Abu Rahman, A. N., Tett, S. E. and Staatz, C. E. (2013). A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients. Population Approach Group in Australia and New Zealand conference, Brisbane, QLD, Australia, February 2013.

A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au